Evidence map›Paper›PMID 37833506›Full record

ArticleAMB Express2023

Synthesis of Ni

Alireza Shariati, Sara Ali Hosseinzadeh, Zahra Barghi, Sogand Sadat Mortazavi, Kosar Atarod, Fatemeh Sadat Shariati, Behrokh Farahmand

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AMB Express, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alireza ShariatiDepartment of Materials Engineering, Tarbiat Modares University, P.O. Box 14115-143, Tehran, Iran.
Sara Ali HosseinzadehDepartment of Nanobiotechnology, New Technologies Research Group, Pasteur Institute of Iran, Tehran, Iran.
Zahra BarghiInfuenza Research Lab, Pasteur Institute of Iran, Tehran, Iran.
Sogand Sadat MortazaviFarzanegan high school, National Organization for Development of Exceptional Talents, Tehran, Iran.
Kosar AtarodFarzanegan high school, National Organization for Development of Exceptional Talents, Tehran, Iran.
Fatemeh Sadat ShariatiInfuenza Research Lab, Pasteur Institute of Iran, Tehran, Iran. fshareati@yahoo.com.
Behrokh FarahmandInfuenza Research Lab, Pasteur Institute of Iran, Tehran, Iran. b_farahmand@pasteur.ac.ir.
Pasteur Institute of Iran · IRTarbiat Modares University · IR

Funding

Alireza shariati Alireza shariatiFatemeh sadat shariati Fatemeh sadat shariati
6 · The paper itself

Abstract

Facilitated purification of proteins, at a low cost and a short time, is one of the key steps in the industrial production of recombinant proteins. In the current study, polydopamine nanoparticles (PDA-NPs) are considered in the synthesis of magnetic beads for purifying recombinant proteins due to advantages such as biocompatibility/ biodegradability, easy synthesis, as well as the ability to directly chelate metal ions. They were synthesized in Tris buffer (pH: 8:5), then chelated with Fe

Indexed as

Facillated purificationHis-tagged proteinMagnetic beadsPolydopamineRecombinant protein

Identifiers

PMID37833506
PMCPMC10575826
OpenAlexW4387614188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.